2,4,7-Trichloropyrido[2,3-d]pyrimidine

Catalog No.: 
ACPAUI932
CAS No.: 
938443-20-0
Molecular Formula: 
C7H2Cl3N3
Molecular Weight: 
234.47
2,4,7-Trichloropyrido[2,3-d]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$81.00In stockInquiry
5g95%$330.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,4,7-Trichloropyrido[2,3-d]pyrimidine
IUPAC Name2,4,7-trichloropyrido[2,3-d]pyrimidine
MDL No.MFCD11109463
Molecular FormulaC7H2Cl3N3
Molecular Weight234.47
SMILESClC1=NC2=C(C=C1)C(Cl)=NC(Cl)=N2
InChI KeyDNFDLCRLLQVUQK-UHFFFAOYSA-N
Synonym2,4,7-trichloro-pyrido[2,3-d]pyrimidine
CAS No.938443-20-0
PubChem CID37819133

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H317-H319
Precautionary Statement(s)
P280-P305+P351+P338-P411+P235

Synthetic Route by SureRoute

1. ACPAUI932 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACPLXM640 route compound structure diagram
    ACPLXM640938443-19-7In Stock
  6. Then
  7. ACPAUI932 route product structure diagram
    ACPAUI932938443-20-0In Stock
Inquiry

2. ACPAUI932 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPAUI932 route compound structure diagram
    ACPAUI932938443-20-0In Stock
  4. Then
  5. ACPAUI932 route product structure diagram
    ACPAUI932938443-20-0In Stock
Inquiry

3. ACPAUI932 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPAUI932 route product structure diagram
    ACPAUI932938443-20-0In Stock
Inquiry

Comments (0)